Current guidelines on supplemental imaging for screening women with dense breasts are conflicting and must evolve say experts reacting to the new study findings.
FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.
Contrast-enhanced mammography offers a reliable alternative to MRI in evaluating nipple-areola complex involvement in patients with breast cancer before surgery.
Can AI match radiologists in prostate MRI diagnosis? The PARADIGM trial will assess AI detection of clinically significant ...
Manganese oxide nanoparticles (Mn 3 O 4 NPs) were synthesized and modified with an LHRH-targeting peptide or anti-melanoma antibodies (cancer-targeting moieties), as well as an MMP2 cleavable peptide ...
Of the 103 patients with CPS recommended for WB-MRI surveillance, 59 underwent the procedure (57% uptake rate). Among them, 34 (57%) were female and the median age was 32 years (range, 1-74 years).
I revved up my longevity protocols and sought out the latest predictive screenings. Was I seizing control of my health or ...
The Brain Tumor Foundation will offer free MRI screenings for early detection of brain tumors at the Sid Jacobson JCC from Sunday, June 15, through Friday, June 20. The screenings are part of the ...
An advantage of whole-body MRIs over CTs is that they use magnets and radio waves, which eliminate the type of radiation linked to cancer. But that doesn’t mean they’re risk-free or the right choice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results